Table 3 Additive interactions of different fatty acids and abdominal obesity on incident MVDsa

From: Associations of abdominal obesity and plasma fatty acids with microvascular diseases

Fatty acids

RERI

AP

SI

SFAs

0.02 (−0.09, 0.13)

0.01 (−0.07, 0.10)

1.07 (0.70, 1.63)

MUFAs

0.07 (−0.04, 0.19)

0.06 (−0.03, 0.14)

1.32 (0.79, 2.19)

Total PUFAs

0.00 (−0.10, 0.10)

0.00 (−0.10, 0.10)

1.01 (0.15, 7.07)

n-3 PUFAs

−0.14 (−0.25, −0.03)

−0.12 (−0.22, −0.03)

0.49 (0.31, 0.79)

n-6 PUFAs

0.00 (−0.10, 0.11)

0.00 (−0.10, 0.10)

1.00 (0.29, 3.45)

  1. aData are presented as the point estimate (95% CI) for the additive interaction metrics. The regression model was adjusted for age, sex, ethnicity, deprivation index, education level, dietary score, alcohol, smoking status, physical activity, eGFR, dyslipidemia, hypertension, and type 2 diabetes. Reference group: participants without abdominal obesity and with fatty acid levels below the median.
Back to article page